Renaissance Technologies’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $446K | Sell |
24,262
-22,438
| -48% | -$258K | ﹤0.01% | 2648 |
|
|
2025
Q4 | $554K | Buy |
46,700
+19,800
| +74% | +$252K | ﹤0.01% | 2536 |
|
|
2025
Q3 | $320K | Buy |
+26,900
| New | +$357K | ﹤0.01% | 2973 |
|
|
2025
Q1 | – | Sell |
-412
| Closed | -$10.2K | – | 3597 |
|
|
2024
Q4 | $10.2K | Sell |
412
-7,399
| -95% | -$202K | ﹤0.01% | 3519 |
|
|
2024
Q3 | $132K | Sell |
7,811
-458
| -6% | -$9.61K | ﹤0.01% | 3209 |
|
|
2024
Q2 | $233K | Buy |
8,269
+6,852
| +484% | +$712K | ﹤0.01% | 3003 |
|
|
2024
Q1 | $425K | Buy |
1,417
+173
| +14% | +$51.7K | ﹤0.01% | 2926 |
|
|
2023
Q4 | $294K | Sell |
1,244
-767
| -38% | -$119K | ﹤0.01% | 2997 |
|
|
2023
Q3 | $302K | Buy |
2,011
+850
| +73% | +$134K | ﹤0.01% | 2928 |
|
|
2023
Q2 | $202K | Sell |
1,161
-270
| -19% | -$45.3K | ﹤0.01% | 3303 |
|
|
2023
Q1 | $180K | Sell |
1,431
-1,139
| -44% | -$256K | ﹤0.01% | 3321 |
|
|
2022
Q4 | $779K | Sell |
2,570
-2,693
| -51% | -$397K | ﹤0.01% | 2676 |
|
|
2022
Q3 | $290K | Sell |
5,263
-401
| -7% | -$28.8K | ﹤0.01% | 3225 |
|
|
2022
Q2 | $339K | Buy |
5,664
+958
| +20% | +$70.9K | ﹤0.01% | 3384 |
|
|
2022
Q1 | $536K | Sell |
4,706
-1,307
| -22% | -$153K | ﹤0.01% | 3143 |
|
|
2021
Q4 | $866K | Buy |
6,013
+52
| +0.9% | +$9.44K | ﹤0.01% | 2753 |
|
|
2021
Q3 | $1.3M | Sell |
5,961
-1,616
| -21% | -$342K | ﹤0.01% | 2400 |
|
|
2021
Q2 | $1.76M | Buy |
7,577
+1,312
| +21% | +$334K | ﹤0.01% | 2341 |
|
|
2021
Q1 | $1.89M | Sell |
6,265
-898
| -13% | -$322K | ﹤0.01% | 2268 |
|
|
2020
Q4 | $2.69M | Buy |
7,163
+4,616
| +181% | +$1.62M | ﹤0.01% | 1952 |
|
|
2020
Q3 | $782K | Sell |
2,547
-3,269
| -56% | -$1.25M | ﹤0.01% | 2638 |
|
|
2020
Q2 | $2.19M | Buy |
5,816
+2,580
| +80% | +$731K | ﹤0.01% | 2142 |
|
|
2020
Q1 | $738K | Buy |
+3,236
| New | +$1.24M | ﹤0.01% | 2574 |
|
|
2019
Q1 | – | Sell |
-873
| Closed | -$826K | – | 3536 |
|
|
2018
Q4 | $826K | Buy |
+873
| New | +$1.05M | ﹤0.01% | 2664 |
|
|
2018
Q1 | – | Sell |
-1,745
| Closed | -$2.93M | – | 3436 |
|
|
2017
Q4 | $2.93M | Sell |
1,745
-717
| -29% | -$948K | ﹤0.01% | 2124 |
|
|
2017
Q3 | $3.44M | Buy |
2,462
+2,355
| +2,201% | +$2.76M | ﹤0.01% | 1988 |
|
|
2017
Q2 | $119K | Sell |
107
-753
| -88% | -$622K | ﹤0.01% | 3069 |
|
|
2017
Q1 | $467K | Sell |
860
-319
| -27% | -$196K | ﹤0.01% | 2785 |
|
|
2016
Q4 | $719K | Sell |
1,179
-162
| -12% | -$101K | ﹤0.01% | 2662 |
|
|
2016
Q3 | $959K | Buy |
1,341
+195
| +17% | +$149K | ﹤0.01% | 2587 |
|
|
2016
Q2 | $833K | Buy |
1,146
+454
| +66% | +$313K | ﹤0.01% | 2607 |
|
|
2016
Q1 | $412K | Buy |
692
+83
| +14% | +$42.6K | ﹤0.01% | 2895 |
|
|
2015
Q4 | $348K | Buy |
609
+131
| +27% | +$86.8K | ﹤0.01% | 2847 |
|
|
2015
Q3 | $268K | Sell |
478
-115
| -19% | -$83K | ﹤0.01% | 2810 |
|
|
2015
Q2 | $471K | Buy |
593
+170
| +40% | +$141K | ﹤0.01% | 2742 |
|
|
2015
Q1 | $352K | Buy |
+423
| New | +$328K | ﹤0.01% | 2707 |
|
Other funds holding CBIO
BI
FFM
VA
FIS
VPC
OM
TCM
VCM